JWA
RVMD icon

JFS Wealth Advisors’s Revolution Medicines RVMD Stock Holding History

JFS Wealth Advisors’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.24K Hold
44
– – ﹤0.01% 1093
2026
Q1 		$4.28K Hold
44
– – ﹤0.01% 1248
2025
Q4 		$3.5K Buy
44
+25
+132% +$1.64K ﹤0.01% 1378
2025
Q3 		$888 Buy
19
+1
+6% +$39 ﹤0.01% 1656
2025
Q2 		$663 Buy
18
+10
+125% +$384 ﹤0.01% 1645
2025
Q1 		$283 Hold
8
– – ﹤0.01% 1824
2024
Q4 		$350 Hold
8
– – ﹤0.01% 1817
2024
Q3 		$363 Hold
8
– – ﹤0.01% 1833
2024
Q2 		$311 Hold
8
– – ﹤0.01% 1861
2024
Q1 		$258 Sell
8
-4
-33% -$119 ﹤0.01% 1870
2023
Q4 		$345 Sell
12
-9
-43% -$216 ﹤0.01% 1849
2023
Q3 		$582 Buy
21
+14
+200% +$415 ﹤0.01% 1717
2023
Q2 		$188 Buy
7
+2
+40% +$49 ﹤0.01% 1882
2023
Q1 		$109 Buy
+5
New +$123 ﹤0.01% 1883

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

JFS Wealth Advisors's RVMD Position: Q2 2026 in Review

JFS Wealth Advisors held its Revolution Medicines (RVMD) position steady in Q2 2026 at 44 shares worth $8.24K. The position accounts for ﹤0.01% of the portfolio, ranked #1093.

JFS Wealth Advisors first reported a position in RVMD in Q1 2023 and has held it in 14 quarters since. 690 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • JFS Wealth Advisors held 44 shares of Revolution Medicines worth $8.24K as of Q2 2026.
  • JFS Wealth Advisors left its Revolution Medicines share count unchanged in Q2 2026.
  • Revolution Medicines made up ﹤0.01% of JFS Wealth Advisors's portfolio in Q2 2026, its #1093 holding.
  • JFS Wealth Advisors first reported a position in Revolution Medicines in Q1 2023 and has held it in 14 quarters since.
  • 690 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on JFS Wealth Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.